Related references
Note: Only part of the references are listed.Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
George M. Burslem et al.
CELL (2020)
Discovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases Inhibitors
Yaxi Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor
Jonathan E. Wilson et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex
Jessie Hao-Ru Hsu et al.
CELL CHEMICAL BIOLOGY (2020)
Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical Degrader
Frances Potjewyd et al.
CELL CHEMICAL BIOLOGY (2020)
Development and Characterization of a Wee1 Kinase Degrader
Zhengnian Li et al.
CELL CHEMICAL BIOLOGY (2020)
PROTACs: An Emerging Therapeutic Modality in Precision Medicine
Dhanusha A. Nalawansha et al.
CELL CHEMICAL BIOLOGY (2020)
PROTAC-mediated degradation of class I histone deacetylase enzymes in corepressor complexes
Joshua P. Smalley et al.
CHEMICAL COMMUNICATIONS (2020)
Development of Dual and Selective Degraders of Cyclin-Dependent Kinases 4 and 6
Baishan Jiang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Combination Targeting of the Bromodomain and Acetyltransferase Active Site of p300/CBP
Beth E. Zucconi et al.
BIOCHEMISTRY (2019)
BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
William Farnaby et al.
NATURE CHEMICAL BIOLOGY (2019)
Bruton tyrosine kinase degradation as a therapeutic strategy for cancer
Dennis Dobrovolsky et al.
BLOOD (2019)
Proteolysis targeting chimeric molecules as therapy for multiple myeloma: efficacy, biomarker and drug combinations
Su Lin Lim et al.
HAEMATOLOGICA (2019)
CREBBP/EP300 Bromodomain Inhibition Affects the Proliferation of AR-Positive Breast Cancer Cell Lines
Veronica Garcia-Carpizo et al.
MOLECULAR CANCER RESEARCH (2019)
Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation
Calla M. Olson et al.
NATURE CHEMICAL BIOLOGY (2018)
Translation Termination Factor GSPT1 Is a Phenotypically Relevant Off-Target of Heterobifunctional Phthalimide Degraders
Mette Ishoey et al.
ACS CHEMICAL BIOLOGY (2018)
Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome
Brian T. Weinert et al.
CELL (2018)
The dTAG system for immediate and target-specific protein degradation
Behnam Nabet et al.
NATURE CHEMICAL BIOLOGY (2018)
Plasticity in binding confers selectivity in ligand-induced protein degradation
Radoslaw P. Nowak et al.
NATURE CHEMICAL BIOLOGY (2018)
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands
Lara N. Gechijian et al.
NATURE CHEMICAL BIOLOGY (2018)
Delineating the role of cooperativity in the design of potent PROTACs for BTK
Adelajda Zorba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acetyltransferases
Michael R. Michaelides et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Modulating PCAF/GCN5 Immune Cell Function through a PROTAC Approach
Zuni I. Bassi et al.
ACS CHEMICAL BIOLOGY (2018)
Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation
Ryan Raisner et al.
CELL REPORTS (2018)
GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)
F. Anthony Romero et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment
Georg E. Winter et al.
MOLECULAR CELL (2017)
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
Loren M. Lasko et al.
NATURE (2017)
Detection of dysregulated protein-association networks by high-throughput proteomics predicts cancer vulnerabilities
John D. Lapek et al.
NATURE BIOTECHNOLOGY (2017)
An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
M. Ryan Corces et al.
NATURE METHODS (2017)
Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors
Jayme L. Dahlin et al.
NATURE COMMUNICATIONS (2017)
Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer
Lingyan Jin et al.
CANCER RESEARCH (2017)
Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL
Ashton C. Lai et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Characterizing the Covalent Targets of a Small Molecule Inhibitor of the Lysine Acetyltransferase P300
Jonathan H. Shrimp et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression
Hideaki Ogiwara et al.
CANCER DISCOVERY (2016)
Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300
Terry D. Crawford et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
Mary E. Matyskiela et al.
NATURE (2016)
deepTools2: a next generation web server for deep-sequencing data analysis
Fidel Ramirez et al.
NUCLEIC ACIDS RESEARCH (2016)
Heatmapper: web-enabled heat mapping for all
Sasha Babicki et al.
NUCLEIC ACIDS RESEARCH (2016)
Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637)
Alexander M. Taylor et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
Sarah Picaud et al.
CANCER RESEARCH (2015)
Protein Lysine Acetylation by p300/CBP
Beverley M. Dancy et al.
CHEMICAL REVIEWS (2015)
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
Jing Lu et al.
CHEMISTRY & BIOLOGY (2015)
ChIPmentation: fast, robust, low-input ChIP-seq for histones and transcription factors
Christian Schmidt et al.
NATURE METHODS (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses
Ariane Hammitzsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter et al.
SCIENCE (2015)
RFPL3 and CBP synergistically upregulate hTERT activity and promote lung cancer growth
Yu Qin et al.
ONCOTARGET (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
MultiNotch MS3 Enables Accurate, Sensitive, and Multiplexed Detection of Differential Expression across Cancer Cell Line Proteomes
Graeme C. McAlister et al.
ANALYTICAL CHEMISTRY (2014)
Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs
Philip P. Chamberlain et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Gang Lu et al.
SCIENCE (2014)
Quantitative ChIP-Seq Normalization Reveals Global Modulation of the Epigenome
David A. Orlando et al.
CELL REPORTS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
Presenting your structures: the CCP4mg molecular-graphics software
S. McNicholas et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Probing the reaction coordinate of the p300/CBP histone acetyltransferase with bisubstrate analogs
Kannan R. Karukurichi et al.
BIOORGANIC CHEMISTRY (2011)
MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics
Lily Ting et al.
NATURE METHODS (2011)
The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation
Lan Wang et al.
SCIENCE (2011)
A Tissue-Specific Atlas of Mouse Protein Phosphorylation and Expression
Edward L. Huttlin et al.
CELL (2010)
Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
Erin M. Bowers et al.
CHEMISTRY & BIOLOGY (2010)
Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases
David C. Bedford et al.
EPIGENETICS (2010)
A generalized approach to sampling backbone conformations with RosettaDock for CAPRI rounds 13-19
Aroop Sircar et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
Ji Luo et al.
CELL (2009)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry
Joshua E. Elias et al.
NATURE METHODS (2007)
Role of the NEDD8 modification of CuI2 in the sequential activation of ECV complex
Roxana I. Sufan et al.
NEOPLASIA (2006)
Bio3d: an R package for the comparative analysis of protein structures
Barry J. Grant et al.
BIOINFORMATICS (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors
V Sagar et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13)
I Panagopoulos et al.
HUMAN MOLECULAR GENETICS (2001)
Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation
I Kitabayashi et al.
LEUKEMIA (2001)
Share Paper
